E-LIB Suche - Ergebnisse für: Fagan, S. C.

1

Secondary Preventive Medication Persistence and Adherence O..:

Bushnell, C. D. ; Olson, D. M. ; Zhao, X....
Neurology. 99 (2012) 9 - p. 5-6 , 2012

Link: https://doi.org/10.1212/

2

Secondary preventive medication persistence and adherence 1..:

Bushnell, C.D. ; Olson, D.M. ; Zhao, X....
Neurology. 77 (2011) 12 - p. 1182-1190 , 2011

Link: https://doi.org/10.1212/..

3

Neuroprotective agents for clinical trials in ALS: A system..:

Traynor, B. J. ; Bruijn, L. ; Conwit, R....
Neurology. 67 (2006) 1 - p. 20-27 , 2006

Link: https://doi.org/10.1212/..

4

Neuroprotective agents for clinical trials in Parkinson's d..:

Ravina, B.M. ; Fagan, S.C. ; Hart, R.G....
Neurology. 60 (2003) 8 - p. 1234-1240 , 2003

Link: https://doi.org/10.1212/..

5

Cost-effectiveness of tissue plasminogen activator for acut..:

Riggs, J. E. ; Nadareishvili, Z. ; Oh, P....
Neurology. 52 (1999) 4 - p. 894-894 , 1999

Link: https://doi.org/10.1212/..

6

Prediction of Impending Hemorrhagic Transformation in Ische..:

Knight, R. A. ; Barker, P. B. ; Fagan, S. C....
Stroke. 29 (1998) 1 - p. 144-151 , 1998

Link: https://doi.org/10.1161/..

7

Neuropsychological Dose Effects of a Freon, Trifluoromethan..:

Rahill, A.A ; Brown, G.G ; Fagan, S.C...
Neurotoxicology and Teratology. 20 (1998) 6 - p. 617-626 , 1998

Link: https://doi.org/10.1016/..

8

Cost-effectiveness of tissue plasminogen activator for acut..:

Fagan, S. C. ; Morgenstern, L. B. ; Petitta, A....
Neurology. 50 (1998) 4 - p. 883-890 , 1998

Link: https://doi.org/10.1212/..

9

Fluorocarbon-23 measure of cat cerebral blood flow by nucle..:

Ewing, J R ; Branch, C A ; Fagan, S C...
Stroke. 21 (1990) 1 - p. 100-106 , 1990

Link: https://doi.org/10.1161/..

10

Acute toxicity of a nuclear magnetic resonance cerebral blo..:

Branch, C A ; Ewing, J R ; Fagan, S C..
Stroke. 21 (1990) 8 - p. 1172-1177 , 1990

Link: https://doi.org/10.1161/..

11

Effect of nimodipine on blood pressure in acute ischemic st..:

Fagan, S C ; Gengo, F M ; Bates, V..
Stroke. 19 (1988) 3 - p. 401-402 , 1988

Link: https://doi.org/10.1161/..

12

Impact of chronic consumption of dairy products varying in ..:

Markey, O. ; Vasilopoulou, D. ; Fagan, C.C....
Proceedings of the Nutrition Society. 76 (2017) OCE2 - p. , 2017

Link: https://doi.org/10.1017/..

13

A comparison of chronic consumption of dairy products varyi..:

Vasilopoulou, D. ; Markey, O. ; Fagan, C.C....
Proceedings of the Nutrition Society. 76 (2017) OCE4 - p. , 2017

Link: https://doi.org/10.1017/..

14

Chronic consumption of conventional and saturated-fat reduc..:

Vasilopoulou, D. ; Markey, O. ; Fagan, C.C....
Proceedings of the Nutrition Society. 75 (2016) OCE3 - p. , 2016

Link: https://doi.org/10.1017/..

15

Impact of fatty acid-modified dairy product consumption on ..:

Markey, O. ; Vasilopoulou, D. ; Fagan, C.C....
Proceedings of the Nutrition Society. 75 (2016) OCE3 - p. , 2016

Link: https://doi.org/10.1017/..